Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Epilepsy

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 0 · 0%High 0 · 0%

Seizure freedom · patients with drug‐resistant epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Intravenous immunoglobulins for epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Satisfactory seizure control 50% or greater reduction in seizure frequency for drug‐resistant epilepsy · patients with drug‐resistant epilepsy

IVIg showed no clear difference in satisfactory seizure control 50% or greater reduction in seizure… compared with placebo (low certainty).

1 finding from 1 review

Intravenous immunoglobulins for epilepsy 2019 · Cochrane Headline outcomes only
RR 1.89 [0.85, 4.21]
1 study · 58 participants
Low

All harmful effects · patients with drug‐resistant epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Intravenous immunoglobulins for epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Global assessment · patients with drug‐resistant epilepsy

IVIg may leads to higher global assessment compared with placebo (low certainty).

1 finding from 1 review

Intravenous immunoglobulins for epilepsy 2019 · Cochrane Headline outcomes only
RR 3.29 [1.13, 9.57]
1 study · 60 participants
Low